SCHEMBL19398873

SCHEMBL19398873

COC(=O)c1ccc(CS(=O)(=O)c2ccc(NC(=O)Oc3ccccc3)cc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.57
▸ MAPT P10636 6/20 0.56
▸ ALDH1A1 P00352 5/20 0.56
▸ HPGD P15428 2/20 0.56
▸ MEN1 O00255 2/20 0.56
▸ THRB P10828 2/20 0.56
▸ KMT2A Q03164 2/20 0.56
▸ RAB9A P51151 2/20 0.53
▸ LMNA P02545 3/20 0.49
▸ NPC1 O15118 1/20 0.49
▸ KDM4E B2RXH2 3/20 0.48
▸ GLA P06280 1/20 0.48
▸ GAA P10253 1/20 0.48
▸ ATM Q13315 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.48
▸ GRK2 P25098 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ RECQL P46063 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20389159 0.88 ALDH1A1 (0.60) MAPTALDH1A1HPGDMEN1THRB
SCHEMBL2197321 0.84 ALDH1A1 (0.70) POLBMAPTALDH1A1HPGDMEN1
SCHEMBL19398872 0.83 ALDH1A1 (0.64) POLBMAPTALDH1A1HPGDMEN1
SCHEMBL3916464 0.83 POLB (0.62) POLBMAPTALDH1A1RAB9AKDM4E
SCHEMBL24756023 0.80 ALDH1A1 (0.68) MAPTALDH1A1HPGDMEN1THRB
SCHEMBL10900058 0.77 ALDH1A1 (0.62) MAPTALDH1A1HPGDMEN1THRB
SCHEMBL12549885 0.76 RAB9A (0.88) MAPTALDH1A1HPGDMEN1THRB
SCHEMBL19398871 0.75 CYP3A4 (0.60) POLBMAPTKMT2ATSHRHSD17B10
SCHEMBL7165531 0.75 POLB (0.65) POLBMAPTMEN1KMT2ARAB9A
SCHEMBL23329736 0.75 LMNA (0.61) POLBMAPTALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US disclosed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US disclosed
WO-2017162390-A1 BENZENESULFONYL-ASYMMETRIC UREAS AND MEDICAL USES THEREOF HELSINN HEALTHCARE SA (CH) 2017-09-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof UTS2R, GHSR, GRPR POLB 4389/4885MAPT 3586/4885ALDH1A1 3527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback